Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostaglandin and Cannabinoid Receptors in the Development of Eosinophilic Esophagitis

NCT04626609 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT04626609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04626609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostaglandin and Cannabinoid Receptors in the Development of Eosinophilic Esophagitis
Lead sponsor
Medical University of Graz
Phase
Observational
Overall status
Completed
Start date
July 1, 2021
Completion date
November 18, 2024
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eosinophilic esophagitis (eoe)